ScholarIQanswers from OpenAlex & ORCID
Shreyaskumar Patel
ResearcherPublications, citations & collaboration network
Shreyaskumar Patel is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Shreyaskumar Patel have?
ScholarIQindexed works
Shreyaskumar Patel has 449 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Shreyaskumar Patel have?
ScholarIQcitation count
Shreyaskumar Patel has 26,568 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Shreyaskumar Patel?
ScholarIQh-index
Shreyaskumar Patel has an h-index of 81 in OpenAlex.
What is the i10-index of Shreyaskumar Patel?
ScholarIQi10-index
Shreyaskumar Patel has an i10-index of 221 in OpenAlex.
What is the ORCID of Shreyaskumar Patel?
ScholarIQorcid
The ORCID for Shreyaskumar Patel is on the source record.
What is the OpenAlex record for Shreyaskumar Patel?
ScholarIQopenalex
The OpenAlex for Shreyaskumar Patel is on the source record.
What are the most-cited papers on Shreyaskumar Patel?
ScholarIQmost cited works
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack, Brian A. Van Tine, Scott M. Schuetze, James Hu, Sandra P. D’Angelo, Steven Attia, Richard F. Riedel, Dennis A. Priebat, Sujana Movva, Lara E. Davis, Scott H. Okuno, Damon R. Reed, John Crowley, Lisa H. Butterfield, Ruth Salazar, Jaime Rodriguez‐Canales, Alexander J. Lazar, Ignacio I. Wistuba, Laurence H. Baker, Robert G. Maki, Denise K. Reinke, Shreyaskumar Patel
A Novel Classification System for Spinal Instability in Neoplastic Disease
Charles G. Fisher, Christian P. DiPaola, Timothy C. Ryken, Mark H. Bilsky, Christopher I. Shaffrey, Sigurd Berven, James S. Harrop, Michael G. Fehlings, Stefano Boriani, Dean Chou, Meic H. Schmidt, David W. Polly, R. Biagini, Shane Burch, Mark B. Dekutoski, Aruna Ganju, Peter C. Gerszten, Ziya L. Gokaslan, Michael W. Groff, Norbert J. Liebsch, Ehud Mendel, Scott H. Okuno, Shreyaskumar Patel, Laurence D. Rhines, Peter S. Rose, Daniel M. Sciubba, Narayan Sundaresan, Katsuro Tomita, Péter Varga, Luiz Roberto Vialle, Frank D. Vrionis, Yoshiya Yamada, Daryl R. Fourney
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
George D. Demetri, Margaret von Mehren, Robin L. Jones, Martee L. Hensley, Scott M. Schuetze, Arthur P. Staddon, Mohammed Milhem, A. Elias, Kristen N. Ganjoo, Hussein A. Tawbi, Brian Andrew Van Tine, Alexander I. Spira, Andrew Dean, Nushmia Z. Khokhar, Youn Choi Park, Roland E. Knoblauch, Trilok Parekh, Robert G. Maki, Shreyaskumar Patel
Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002
Robert G. Maki, J. Kyle Wathen, Shreyaskumar Patel, Dennis A. Priebat, Scott H. Okuno, Brian L. Samuels, Michael Fanucchi, David C. Harmon, Scott M. Schuetze, Denise K. Reinke, Peter F. Thall, Robert S. Benjamin, Laurence H. Baker, Martee L. Hensley
Spinal Instability Neoplastic Score: An Analysis of Reliability and Validity From the Spine Oncology Study Group
Daryl R. Fourney, Evan Frangou, Timothy C. Ryken, Christian P. DiPaola, Christopher I. Shaffrey, Sigurd Berven, Mark H. Bilsky, James S. Harrop, Michael G. Fehlings, Stefano Boriani, Dean Chou, Meic H. Schmidt, David W. Polly, R. Biagini, Shane Burch, Mark B. Dekutoski, Aruna Ganju, Peter C. Gerszten, Ziya L. Gokaslan, Michael W. Groff, Norbert J. Liebsch, Ehud Mendel, Scott H. Okuno, Shreyaskumar Patel, Laurence D. Rhines, Peter S. Rose, Daniel M. Sciubba, Narayan Sundaresan, Katsuro Tomita, Péter Varga, Luiz Roberto Vialle, Frank D. Vrionis, Yoshiya Yamada, Charles G. Fisher